Geroprotector drugs and exercise: friends or foes on healthy longevity?
Christian J Elliehausen, Rozalyn M Anderson, Gary M Diffee, Timothy W Rhoads, Dudley W Lamming, Troy A Hornberger, Adam R Konopka · 2023
Read Geroprotector drugs and exercise: friends or foes on healthy longevity? by Christian J Elliehausen, Rozalyn M Anderson, Gary M Diffee, Timothy W Rhoads, Dudley W Lamming, Troy A Hornberger, Adam R Konopka (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10709984.txt.
Description
Christian Elliehausen and colleagues ask if longevity drugs and exercise work as a team, or get in each other's way. Physical activity and quite a few drug plans each fight age-linked conditions, and stretch healthy longevity in model systems. To join them might look like a clear win. But the view now held is less rosy: top geroprotector drugs on exercise days may cap quite a few health gains.
The review looks at top candidate geroprotectors and how they act with exercise. Some drugs work through the same paths exercise switches on, spanning nutrient sensing and stress response, so the drug can dull the signal the body uses to adapt. The team flags key gaps in what is known, which must close before we can tell if the drugs sit well with exercise. If a pill wipes out part of a workout's gain, then timing is a clinical call.
Catalog record
| CREATOR | Christian J Elliehausen, Rozalyn M Anderson, Gary M Diffee, Timothy W Rhoads, Dudley W Lamming, Troy A Hornberger, Adam R Konopka |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 47 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |